Scholar Rock Holding (SRRK) Change in Accured Expenses (2017 - 2026)
Scholar Rock Holding's quarterly Change in Accured Expenses came in at $4.7 million in Q1 2026, up 236.76% year-on-year from $1.4 million in Q1 2025, and up 145.48% quarter-over-quarter from -$10.3 million in Q4 2025.
Scholar Rock Holding has reported Change in Accured Expenses for 10 years, with the latest figure at $4.7 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses rose 236.76% year-over-year to $4.7 million; the trailing twelve-month figure through Mar 2026 stood at $16.6 million (up 170.27% YoY), and the FY2025 full-year result was $8.5 million, down 19.31% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at $4.7 million, up from -$10.3 million in the prior quarter.
- The five-year high for Change in Accured Expenses was $16.4 million in Q2 2025, with the low at -$10.3 million in Q4 2025.
- Average Change in Accured Expenses over 5 years is $1.6 million, with a median of $1.6 million recorded in 2022.
- Peak annual rise in Change in Accured Expenses reached 3230.83% in 2025, while the deepest fall reached 663.35% in 2025.
- Tracing SRRK's Change in Accured Expenses over 5 years: stood at $1.6 million in 2022, then jumped by 91.26% to $3.0 million in 2023, then sank by 39.01% to $1.8 million in 2024, then plunged by 663.35% to -$10.3 million in 2025, then soared by 145.48% to $4.7 million in 2026.
- The last three Change in Accured Expenses figures came in at $4.7 million (Q1 2026), -$10.3 million (Q4 2025), and $5.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 931,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 70.50 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 107.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -176.03 Mn |
| 10 | Scholar Rock Holding | 500.61 Mn | 20.67 Mn | - | 4.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.68 Mn |
| Mar 31, 2026 | 4.68 Mn |
| Dec 31, 2025 | -10.30 Mn |
| Dec 31, 2025 | -10.30 Mn |
| Sep 30, 2025 | 5.80 Mn |
| Sep 30, 2025 | 5.80 Mn |
| Jun 30, 2025 | 16.42 Mn |
| Jun 30, 2025 | 16.42 Mn |
| Mar 31, 2025 | -3.43 Mn |
| Mar 31, 2025 | -3.43 Mn |
| Dec 31, 2024 | 1.83 Mn |
| Dec 31, 2024 | 1.83 Mn |
| Sep 30, 2024 | 7.25 Mn |
| Sep 30, 2024 | 7.25 Mn |
| Jun 30, 2024 | 493,000.00 |
| Jun 30, 2024 | 493,000.00 |
| Mar 31, 2024 | 963,000.00 |
| Mar 31, 2024 | 963,000.00 |
| Dec 31, 2023 | 3.00 Mn |
| Dec 31, 2023 | 3.00 Mn |
| Sep 30, 2023 | 3.59 Mn |
| Sep 30, 2023 | 3.59 Mn |
| Jun 30, 2023 | -925,000.00 |
| Jun 30, 2023 | -925,000.00 |
| Mar 31, 2023 | -9.59 Mn |
| Mar 31, 2023 | -9.59 Mn |
| Dec 31, 2022 | 1.57 Mn |
| Dec 31, 2022 | 1.57 Mn |
| Sep 30, 2022 | 5.31 Mn |
| Sep 30, 2022 | 5.31 Mn |
| Jun 30, 2022 | 1.60 Mn |
| Jun 30, 2022 | 1.60 Mn |
| Mar 31, 2022 | -1.58 Mn |
| Mar 31, 2022 | -1.58 Mn |
| Dec 31, 2021 | -457,000.00 |
| Dec 31, 2021 | -457,000.00 |
| Sep 30, 2021 | 2.89 Mn |
| Sep 30, 2021 | 2.89 Mn |
| Jun 30, 2021 | 721,000.00 |
| Jun 30, 2021 | 721,000.00 |
| Mar 31, 2021 | 506,000.00 |
| Mar 31, 2021 | 506,000.00 |
| Dec 31, 2020 | 3.23 Mn |
| Dec 31, 2020 | 3.23 Mn |
| Sep 30, 2020 | 3.24 Mn |
| Sep 30, 2020 | 3.24 Mn |
| Jun 30, 2020 | 857,000.00 |
| Jun 30, 2020 | 857,000.00 |
| Mar 31, 2020 | -2.23 Mn |
| Mar 31, 2020 | -2.23 Mn |
| Dec 31, 2019 | 1.47 Mn |
| Dec 31, 2019 | 1.47 Mn |
| Sep 30, 2019 | 2.76 Mn |
| Sep 30, 2019 | 2.76 Mn |
| Jun 30, 2019 | 1.25 Mn |
| Jun 30, 2019 | 1.25 Mn |
| Mar 31, 2019 | -3.02 Mn |
| Mar 31, 2019 | -3.02 Mn |
| Dec 31, 2018 | 3.82 Mn |
| Dec 31, 2018 | 3.82 Mn |
| Sep 30, 2018 | 352,000.00 |
| Sep 30, 2018 | 352,000.00 |
| Jun 30, 2018 | 1.46 Mn |
| Jun 30, 2018 | 1.46 Mn |
| Mar 31, 2018 | -1.27 Mn |
| Mar 31, 2018 | -1.27 Mn |
| Dec 31, 2017 | 1.47 Mn |
| Dec 31, 2017 | 1.47 Mn |
| Sep 30, 2017 | 98,000.00 |
| Sep 30, 2017 | 98,000.00 |